Cetuximab in combination with capecitabine, irinotecan and concurrent radiotherapy (CAPIRI-RT) for preoperative treatment of locally advanced rectal cancer

被引:0
|
作者
Hofheinz, RD
Horisberger, K
Tiefenbacher, U
Wenz, F
von Gerstenberg, B
Kähler, G
Post, S
Hochhaus, A
Willeke, F
机构
[1] Onkol Zentrum, Mannheim, Germany
[2] Med Klin 3, Mannheim, Germany
[3] Chirurg Klin, Mannheim, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Phase II trial of preoperative capecitabine with concurrent radiotherapy in patients with locally advanced rectal cancer.
    Arias, F.
    de las Heras, M.
    del Moral, R.
    Gomez Millan, J.
    Jimenez, E.
    Wals, A.
    Alcantara, P.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S132 - S133
  • [22] Phase I trial of preoperative cetuximab in combination with oxaliplatin, capecitabine, and radiation therapy for locally advanced rectal cancer
    Cabebe, E. C.
    Kuo, T.
    Koong, A.
    Welton, M.
    Shelton, A.
    Kunz, P. L.
    Ford, J. M.
    Sikic, B. I.
    Kaiser, H. L.
    Rogers, J.
    Fisher, G. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [23] Prospective phase II trial of nimotuzumab in combination with radiotherapy and concurrent capecitabine in locally advanced rectal cancer
    Jin, Ting
    Zhu, Yuan
    Luo, Jia-Lin
    Zhou, Ning
    Li, De-Chuan
    Ju, Hai-Xin
    Fan, Yong-Tian
    Liu, Yong
    Zhu, Yu-Ping
    Feng, Hai-Yang
    Liu, Lu-Ying
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2015, 30 (03) : 337 - 345
  • [24] Prospective phase II trial of nimotuzumab in combination with radiotherapy and concurrent capecitabine in locally advanced rectal cancer
    Ting Jin
    Yuan Zhu
    Jia-Lin Luo
    Ning Zhou
    De-Chuan Li
    Hai-Xin Ju
    Yong-Tian Fan
    Yong Liu
    Yu-Ping Zhu
    Hai-Yang Feng
    Lu-Ying Liu
    [J]. International Journal of Colorectal Disease, 2015, 30 : 337 - 345
  • [25] Advanced Rectal Cancer: Preoperative Treatment with Oral Capecitabine and Radiotherapy
    Santoro, M.
    Cicero, G.
    Condemi, G.
    Mirabelli, R.
    Petitto, P.
    Furina, C.
    Molica, S.
    Pingitore, D.
    [J]. ONCOLOGY, 2009, 77 : 158 - 158
  • [26] Genotype-driven study of weekly irinotecan and capecitabine in combination with neoadjuvant radiotherapy of locally advanced rectal cancer
    Zhang, Zhen
    Zhu, Ji
    Shen, Yunzhu
    Wan, Juefeng
    Li, Guichao
    Xu, Ye
    Li, Xinxiang
    Cai, Sanjun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [27] Multicenter phase II clinical trial of preoperative capecitabine with concurrent radiotherapy in patients with locally advanced rectal cancer
    de las Heras, Manuel
    Arias, Fernando
    del Moral-Avila, Rosario
    Gomez-Millan, Jaime
    Jimenez, Encarnacion
    Wals, Amadeo
    Luis Tisaire, Jose
    Pino Alcantara, Ma
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2013, 15 (04): : 294 - 299
  • [28] Multicenter phase II clinical trial of preoperative capecitabine with concurrent radiotherapy in patients with locally advanced rectal cancer
    Manuel de las Heras
    Fernando Arias
    Rosario del Moral-Avila
    Jaime Gómez-Millán
    Encarnación Jiménez
    Amadeo Wals
    Jose Luis Tisaire
    Ma Pino Alcantara
    [J]. Clinical and Translational Oncology, 2013, 15 : 294 - 299
  • [29] Preoperative Radiotherapy, Capecitabine and Cetuximab for Locally Advanced Rectal Cancer - Long Term Results of the XERT Phase II Trial
    Velenik, V.
    Ocvirk, J.
    Oblak, I.
    Anderluh, F.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S404 - S404
  • [30] RESULTS FROM THE PHASE II XERT STUDY: NEOADJUVANT CETUXIMAB, CAPECITABINE, AND RADIOTHERAPY (RT) IN LOCALLY ADVANCED RESECTABLE RECTAL CANCER
    Velenik, V.
    Ocvirk, J.
    Oblak, I
    Anderluh, F.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 : 109 - 109